Related Experiment Video
Updated: Jun 13, 2025
09:00
Modeling the Early Steps of Ovarian Cancer Dissemination in an Organotypic Culture of the Human Peritoneal Cavity
Published on: December 31, 2015
26.6K
Ovarian cancer metastasis: Looking beyond the surface
Emine Bayraktar1, Sisy Chen1, Sara Corvigno1
1Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Cancer Cell
|September 13, 2024
Summary
Ovarian cancer (OC) metastasis pathways are more complex than previously thought. This review examines peritoneal, hematogenous, lymphatic, and nerve-related routes in high-grade serous carcinoma (HGSC) to inform better treatments.
Area of Science:
- Oncology
- Cancer Metastasis Research
Background:
- Ovarian cancer (OC) historically assumed surface-to-surface spread.
- Recent findings reveal diverse metastatic pathways.
- High-grade serous carcinoma (HGSC) is the focus due to its heterogeneity.
Purpose of the Study:
- To critically review and synthesize evidence on OC metastatic routes.
- To provide a holistic understanding of HGSC metastasis.
- To identify mechanisms crucial for improving treatment strategies.
Main Methods:
- Comprehensive literature review of OC metastasis.
- Analysis of evidence supporting various spread mechanisms.
- Focus on peritoneal, hematogenous, lymphatic, and nerve-related pathways.
Main Results:
- Evidence supports multiple routes beyond surface spread for HGSC.
- Peritoneal spread remains significant.
- Hematogenous, lymphatic, and nerve-related routes are increasingly recognized.
Conclusions:
- Understanding diverse metastatic mechanisms is vital for effective OC treatment.
- Targeting specific routes may offer novel therapeutic strategies.
- Further research into HGSC metastasis pathways is warranted.
Related Concept Videos
02:30Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
02:53Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
01:35Cancer Cell Migration through Invadopodia
2.3K
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.3K
02:07Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K